Avraham Travers

Statistics

Publications

Citations

200

H-Index

Active since

1992

Affiliations

Walter and Eliza Hall Institute of Medical Research(Current)

Peter MacCallum Cancer Centre

The University of Melbourne

The University of Queensland

Australian National University

Avraham Travers is an author at Walter and Eliza Hall Institute of Medical Research specializing in hormonal therapy, recommended phase ii dose, and rights of persons with disabilities.

ORCID

Publications per year

1992–2024

Publications

A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2–Positive Metastatic Breast Cancer

Sheau Wen Lok, James R. Whittle, François Vaillant et al. · Cancer Discovery · 2019 · 145 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

The CD8+ T cell tolerance checkpoint triggers a distinct differentiation state defined by protein translation defects

Willem Van Der Byl, Simone Nüssing, Timothy J. Peters et al. · Immunity · 2024 · 27 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

A survey of hospital toilet facilities.

Avraham Travers, Edith Burns, N. D. PENN et al. · BMJ · 1992 · 15 citations · Full text

Social Sciences, Health Services Administration, Disability +9

Real-World Treatment and Outcomes of Metastatic Colorectal Cancer Patients With a Poor or Very Poor Performance Status

Avraham Travers, Azim Jalali, Stephen Begbie et al. · Clinical Colorectal Cancer · 2020 · 13 citations

Medicine, Oncology, Surgery +16

1–4 of 4